Growth Equity Opportunities IV, LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Growth Equity Opportunities IV, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Growth Equity Opportunities IV, LLC. Growth Equity Opportunities IV, LLC is a 10% Owner in ARCA biopharma, Inc. ($ABIO) and a 10% Owner in Achaogen Inc ($AKAO) and a 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and a 10% Owner in Cascadian Therapeutics, Inc. ($CASC).
Address: 1954 GREENSPRING DRIVE, SUITE 600 TIMONIUM 21093 MD
Companies in which Growth Equity Opportunities IV, LLC is an Insider
Achaogen, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Growth Equity Opportunities IV, LLC: 10% Owner
Holdings: 5,215,128 shares
Current Value: $98,305,163
Latest Transaction: Dec 19 2016
$AKAO Market Capitalization: $541.33M
$AKAO Previous Close: $18.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARCA biopharma, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Growth Equity Opportunities IV, LLC: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 27 2018
$ABIO Market Capitalization: $23.40M
$ABIO Previous Close: $2.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AVEO PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Growth Equity Opportunities IV, LLC: 10% Owner
Holdings: 3,952,958 shares
Current Value: $2,411,304
Latest Transaction: Jun 22 2020
$AVEO Market Capitalization: $45.51M
$AVEO Previous Close: $0.61
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cascadian Therapeutics, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Growth Equity Opportunities IV, LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Mar 13 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Growth Equity Opportunities IV, LLC
Sentiment: All, AKAO, ABIO, AVEO, CASC
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2020 | AVEO | AVEO PHARMACEUTICA ... | Growth Equity Opportunities Fu ... | 10% Owner | Buy | P | 5.25 | 1,428,571 | 7,499,998 | 3,952,958 | 2.5 M to 4 M (+56.59 %) |
| Apr 08 2019 | AVEO | AVEO PHARMACEUTICA ... | Growth Equity Opportunities Fu ... | 10% Owner | Option Exercise | P | 1.25 | 4,347,827 | 5,434,784 | 4,347,827 | |
| Apr 08 2019 | AVEO | AVEO PHARMACEUTICA ... | Growth Equity Opportunities Fu ... | 10% Owner | Buy | P | 1.14 | 4,347,827 | 4,956,523 | 25,243,865 | 20.9 M to 25.2 M (+20.81 %) |
| Dec 21 2018 | AVEO | AVEO PHARMACEUTICA ... | Growth Equity Opportunities IV ... | 10% Owner | Buy | P | 1.49 | 300,000 | 448,380 | 20,896,038 | 20.6 M to 20.9 M (+1.46 %) |
| Dec 21 2018 | AVEO | AVEO PHARMACEUTICA ... | Growth Equity Opportunities IV ... | 10% Owner | Buy | P | 1.63 | 200,000 | 326,060 | 20,596,038 | 20.4 M to 20.6 M (+0.98 %) |
| Dec 12 2018 | AVEO | AVEO PHARMACEUTICA ... | Growth Equity Opportunities IV ... | 10% Owner | Buy | P | 1.98 | 61,200 | 121,084 | 20,396,038 | 20.3 M to 20.4 M (+0.30 %) |
| Dec 10 2018 | AVEO | AVEO PHARMACEUTICA ... | Growth Equity Opportunities IV ... | 10% Owner | Buy | P | 1.98 | 26,000 | 51,576 | 20,334,838 | 20.3 M to 20.3 M (+0.13 %) |
View all Growth Equity Opportunities IV, LLC insider transactions.